Breast Cancer-Targets and Therapy

Papers
(The median citation count of Breast Cancer-Targets and Therapy is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
<p>Resistance and Overcoming Resistance in Breast Cancer</p>45
Treatment Strategies Against Triple-Negative Breast Cancer: An Updated Review36
A Review of Modifiable Risk Factors in Young Women for the Prevention of Breast Cancer35
Mangifera indica (Mango): A Promising Medicinal Plant for Breast Cancer Therapy and Understanding Its Potential Mechanisms of Action20
Micropapillary Breast Carcinoma: From Molecular Pathogenesis to Prognosis20
Antiproliferation Activity and Apoptotic Mechanism of Soursop (Annona muricata L.) Leaves Extract and Fractions on MCF7 Breast Cancer Cells20
Polyethyleneimine (PEI) as a Polymer-Based Co-Delivery System for Breast Cancer Therapy20
<p>Knowledge, Attitude and Practice Around Breast Cancer and Mammography Screening Among Jordanian Women</p>18
Breast Cancer: An Overview of Current Therapeutic Strategies, Challenge, and Perspectives17
Potentiating the Cytotoxic Activity of a Novel Simvastatin-Loaded Cubosome against Breast Cancer Cells: Insights on Dual Cell Death via Ferroptosis and Apoptosis13
Combination of Pertuzumab and Trastuzumab in the Treatment of HER2-Positive Early Breast Cancer: A Review of the Emerging Clinical Data12
Targeted Treatment for High-Risk Early-Stage Triple-Negative Breast Cancer: Spotlight on Pembrolizumab11
<p>Alpelisib in the Treatment of Breast Cancer: A Short Review on the Emerging Clinical Data</p>10
The Proper Ki-67 Cut-Off in Hormone Responsive Breast Cancer: A Monoinstitutional Analysis with Long-Term Follow-Up10
Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer10
Systematic Review of Breast-Q: A Tool to Evaluate Post-Mastectomy Breast Reconstruction10
An Update on the Molecular Pathology of Metaplastic Breast Cancer9
<p>Knowledge and Practice of Breast Self-Examination Among Young Women in Tertiary Education in Addis Ababa, Ethiopia</p>9
<p>Inhibition of Yes-Associated Protein-1 (YAP1) Enhances the Response of Invasive Breast Cancer Cells to the Standard Therapy</p>7
Profile of Trastuzumab Deruxtecan in the Management of Patients with HER2-Positive Unresectable or Metastatic Breast Cancer: An Evidence-Based Review7
HER2-Low Breast Cancer: Current Landscape and Future Prospects7
Treating Advanced Unresectable or Metastatic HER2-Positive Breast Cancer: A Spotlight on Tucatinib7
Breast Cancer Management in the Era of Covid-19; Key Issues, Contemporary Strategies, and Future Implications7
Based on BATMAN-TCM to Explore the Molecular Mechanism of Xihuang Pill Regulating Immune Function to Treat Breast Precancerous Lesions7
“Diagnostic and Prognostic Biomarkers of Luminal Breast Cancer: Where are We Now?”7
Heart Sparing Radiotherapy Techniques in Breast Cancer: A Focus on Deep Inspiration Breath Hold7
MicroRNA-223 is Associated with Resistance Towards Platinum-based Chemotherapy and Worse Prognosis in Indonesian Triple-negative Breast Cancer Patients6
<p>A Study on Clinical and Pathological Responses to Neoadjuvant Chemotherapy in Breast Carcinoma</p>6
Treatment and Survivorship Interventions to Prevent Poor Body Image Outcomes in Breast Cancer Survivors6
Genetic Influences in Breast Cancer Drug Resistance6
The Breast Tumor Microenvironment: Could Silicone Breast Implant Elicit Breast Carcinoma?6
<p>The Association of Serum Lipid Levels with Breast Cancer Risks Among Women with Breast Cancer at Felege Hiwot Comprehensive Specialized Hospital, Northwest Ethiopia</p>6
Research Progress on Molecular Subtyping and Modern Treatment of Triple-Negative Breast Cancer6
miR-623 Targets Metalloproteinase-1 and Attenuates Extravasation of Brain Metastatic Triple-Negative Breast Cancer Cells5
Cytochrome 4Z1 Expression is Associated with Unfavorable Survival in Triple-Negative Breast Cancers5
Extreme Oncoplasty: Breast Conservation in Patients with Large, Multifocal, and Multicentric Breast Cancer5
Cancer Treatment-Induced Bone Loss: Role of Denosumab in Non-Metastatic Breast Cancer5
Development and Validation of an MRI Radiomics-Based Signature to Predict Histological Grade in Patients with Invasive Breast Cancer5
Breast Cancer Screening Practice and Associated Factors Among Women Aged 20–70 Years in Urban Settings of SNNPR, Ethiopia5
Factors Predicting Positive Sentinel Lymph Node Biopsy in Clinically Node-Negative Breast Cancer5
Young Women with Breast Cancer in Resource-Limited Settings: What We Know and What We Need to Do Better5
Effect of Chemotherapy on the Gut Microbiome of Breast Cancer Patients During the First Year of Treatment5
<p>Network Pharmacology-Oriented Identification of Key Proteins and Signaling Pathways Targeted by Xihuang Pill in the Treatment of Breast Cancer</p>5
Central Nervous System Metastases from Triple-Negative Breast Cancer: Current Treatments and Future Prospective5
Brain Radiotherapy Combined with Targeted Therapy for HER2-Positive Breast Cancer Patients with Brain Metastases4
Staging of the Axilla in Breast Cancer and the Evolving Role of Axillary Ultrasound4
<p>Intensity-Modulated Radiotherapy with Concomitant Boost After Breast Conserving Surgery: A Phase I–II Trial</p>4
Perceived Barriers and Facilitators to Breast Cancer Screening Among Women in Saudi Arabia4
Identifying Risk Factors of Breast Cancer Among Women Attending Selected Hospitals of Addis Ababa City: Hospital-Based Unmatched Case-Control Study4
A Cross-Sectional Evaluation of Knowledge About Breast Cancer and Perceived Barriers to the Uptake of Mammogram Screening Among Northern Saudi Women: A Population-Based Study4
Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment4
TGF-β-Induced TMEPAI Promotes Epithelial–Mesenchymal Transition in Doxorubicin-Treated Triple-Negative Breast Cancer Cells via SMAD3 and PI3K/AKT Pathway Alteration4
Comparing the Gonadotoxicity of Multiple Breast Cancer Regimens: Important Understanding for Managing Breast Cancer in Pre-Menopausal Women4
Neu Perspectives, Therapies, and Challenges for Metastatic HER2-Positive Breast Cancer4
Economic Evaluation of Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer in the United States4
Androgen Receptor Status in Triple Negative Breast Cancer: Does It Correlate with Clinicopathological Characteristics?4
Assessment of Knowledge and Awareness About Breast Self-Examination Among University Female Students in Saudi Arabia4
Ribociclib in the Treatment of Hormone-Receptor Positive/HER2-Negative Advanced and Early Breast Cancer: Overview of Clinical Data and Patients Selection4
Chloride Intracellular Channel 1 is a Potential Biomarker for Breast Cancer3
Metformin Inducing the Change of Functional and Exhausted Phenotypic Tumor-Infiltrated Lymphocytes and the Correlation with JNK Signal Pathway in Triple-Negative Breast Cancer3
Breast Cancer Subtypes and Prognosis: Answers to Subgroup Classification Questions, Identifying the Worst Subgroup in Our Single-Center Series3
The Effect of Estrogen Receptor Status on Survival in Breast Cancer Patients in Ethiopia. Retrospective Cohort Study3
Differences in Treatment Outcomes Between Patients with HER2-Low versus HER2-Zero, Hormone Receptor-Positive Advanced-Stage Breast Cancer Treated with Ribociclib3
Cross-Platform in-silico Analyses Exploring Tumor Immune Microenvironment with Prognostic Value in Triple-Negative Breast Cancer3
FOXQ1 is Differentially Expressed Across Breast Cancer Subtypes with Low Expression Associated with Poor Overall Survival3
An Magnetic-Targeting Nano-Diagnosis and Treatment Platform for TNBC3
Drug-Resistant Breast Cancer: Dwelling the Hippo Pathway to Manage the Treatment3
Jawbone Cavitation Expressed RANTES/CCL5: Case Studies Linking Silent Inflammation in the Jawbone with Epistemology of Breast Cancer3
In vitro to Clinical Translation of Combinatorial Effects of Doxorubicin and Abemaciclib in Rb-Positive Triple Negative Breast Cancer: A Systems-Based Pharmacokinetic/Pharmacodynamic Modeling Approach3
A Scoping Review on the Status of Female Breast Cancer in Asia with a Special Focus on Nepal3
Breast Cancer Adjuvant Radiotherapy in BRCA1/2, TP53, ATM Genes Mutations: Are There Solved Issues?3
Optimized Radiomics Nomogram Based on Automated Breast Ultrasound System: A Potential Tool for Preoperative Prediction of Metastatic Lymph Node Burden in Breast Cancer3
Therapeutic Role of Annona muricata Fruit and Bee Venom Against MNU-Induced Breast Cancer in Pregnant Rats and its Complications on the Ovaries3
Association of Endocrine Therapy and Dementia in Women with Breast Cancer3
Thyroid Hormone Changes Correlate to Combined Breast Cancer with Primary Thyroid Cancer3
Role of Surgery in Metastatic Breast Cancer: Insights from a Narrative Review3
Disparities in Guideline-Concordant Initial Systemic Treatment in Women with HER2-Negative Metastatic Breast Cancer: A SEER-Medicare Analysis3
Immunotherapy: Constructive Approach for Breast Cancer Treatment3
The Notch Signaling Pathway Contributes to Angiogenesis and Tumor Immunity in Breast Cancer3
Breast Self-Examination Practice and Associated Factors Among Women Attending Family Planning Service in Modjo Public Health Facilities Southwest Ethiopia3
Clinical Characteristics and Survival Outcomes of Patients with De Novo Metastatic Breast Cancer3
Re-Evaluating the Association Between Hormonal Contraception and Breast Cancer Risk3
Clinicopathological Features and Survival Outcomes of Metaplastic Breast Carcinoma – An Observational Multi-Centric Study2
Exploring Real-World HER2-Low Data in Early-Stage Triple-Negative Breast Cancer: Insights and Implications2
Challenges in Detection of Serum Oncoprotein: Relevance to Breast Cancer Diagnostics2
Antibody-Drug Conjugates in Breast Cancer: A Comprehensive Review of How to Selectively Deliver Payloads2
Traditional Chinese Medicine for Breast Cancer: A Review2
Breast Cancer in Italy: Stage and Region Distribution2
Breast Cancer Awareness Among Women in Saudi Arabia: A Systematic Review2
Establishment and Validation of a Model for Disease-Free Survival Rate Prediction Using the Combination of microRNA-381 and Clinical Indicators in Patients with Breast Cancer2
Effectiveness of Psycho-Education Intervention Programme on Coping Strategies Among Jordanian Women Diagnosed with Breast Cancer: A Randomised Controlled Trial2
Diagnosis and Individualized Treatment of Three Primary Malignant Tumors: A Case Report2
Disabling the Nuclear Translocalization of RelA/NF-κB by a Small Molecule Inhibits Triple-Negative Breast Cancer Growth2
Clinical Utility of Eribulin Mesylate in the Treatment of Breast Cancer: A Chinese Perspective2
Diagnostic Value of a Combined Serum α-Hydroxybutyrate Dehydrogenase, Carcinoembryonic Antigen and Glycoantigen 125 Test for Early-Stage Breast Cancer2
The Emerging Roles of Exosomal miRNAs in Breast Cancer Progression and Potential Clinical Applications2
HER2 Low Expression in Primary Male Breast Cancer2
Radiomics Analysis of Breast Lesions in Combination with Coronal Plane of ABVS and Strain Elastography2
Survival and Time to Initiation of Adjuvant Chemotherapy Among Breast Cancer Patients in Uruguay2
Occult Invasive Lobular Carcinoma Presenting as an Axillary Skin Metastatic Lesion Underwent Neoadjuvant Endocrine Therapy and Surgical Resection: A Case Report and Review of Literature2
Weekly vs Every-3-Week Carboplatin with Weekly Paclitaxel in Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: A Retrospective Analysis2
Significance of Nuclear Factor-Kappa B (NF-κB) and Survivin in Breast Cancer and Their Association with Radiosensitivity and Prognosis2
Dual Target of EGFR and mTOR Suppresses Triple-Negative Breast Cancer Cell Growth by Regulating the Phosphorylation of mTOR Downstream Proteins2
Guideline-Based, Multi-Gene Panel Germline Genetic Testing for at-Risk Patients with Breast Cancer2
Cost-Effectiveness of Abemaciclib in Early Breast Cancer Patients: One Size Fits All or Tailoring to Patients’ Needs?1
Therapeutic Advantage of Targeting PRMT5 in Combination with Chemotherapies or EGFR/HER2 Inhibitors in Triple-Negative Breast Cancers1
Ribociclib Plus Letrozole in Italian Male Patients with Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Case Studies of Phase 3b CompLEEment-1 Tria1
Detection of Minimal Residual Disease in the Peripheral Blood of Breast Cancer Patients, with a Multi Marker (MGB-1, MGB-2, CK-19 and NY-BR-1) Assay1
The Potent Novel CDK4/6 Inhibitor TQB3616 in Hormone Receptor Positive Breast Cancer: Preclinical Characterization with in vitro and Human Tumor Xenograft Models [Letter]1
Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated with Metronomic Cyclophosphamide: A Clinical and Translational Prospective Study1
Rhabdomyolysis Induced by the Interaction Between Ribociclib and Statins- Case Report and Literature Review1
Comprehensive Assessment of Immune Phenotype and Its Effects on Survival Outcomes in HER2-Low versus HER2-Zero Breast Cancer1
Amplifying Immune Responses: Microparticulate Vaccine Approach Against Breast Cancer1
The Impact of AC and AC-T Chemotherapy’s Toxicities on Quality of Life Among Women with Breast Cancer in Ethiopia: A Prospective Patient-Reported Outcomes Study1
Validation of a Disease-Free Survival Prediction Model Using UBE2C and Clinical Indicators in Breast Cancer Patients1
Survival Outcomes and Efficacy of Platinum in Early Breast Cancer Patients with Germline BRCA1 or BRCA2 Mutation: A Multicenter Retrospective Cohort Study1
Advances in Single-Cell Sequencing Technology and Its Applications in Triple-Negative Breast Cancer1
Evaluation of Cytotoxicity of the Methanolic Extract of Red Sea Marine Sponge Xestospongia Testudinaria and Its Related Compounds Against MCF-7 Human Breast Cancer Cells1
Psychometric Properties and Factorial Analysis of the Arabic McGill-QoL Questionnaire in Breast Cancer1
ABCB1 Regulates Immune Genes in Breast Cancer1
Pregnancy Associated Invasive Apocrine Carcinoma of the Breast: Case Report from Ethiopia1
Promoter Methylation-Regulated Differentially Expressed Genes in Breast Cancer1
Adherence to Adjuvant Hormonal Therapy and Associated Factors Among Women with Breast Cancer Attending the Tikur Anbessa Specialized Hospital, Addis Ababa Ethiopia, 2019: A Cross-sectional Study1
The Involvement of Insulin-Like Growth Factor 2 Messenger Ribonucleic Acid-Binding Protein 2 in the Regulation of the Expression of Breast Cancer-Related Genes1
Whole Genome Sequencing of Single-Circulating Tumor Cell Ameliorates Unraveling Breast Cancer Heterogeneity1
Predictive and Prognostic Value of TRIM58 Protein Expression in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy1
Can Patients with HER2-Low Breast Cancer Benefit from Anti-HER2 Therapies? A Review1
Identification of GZMA as a Potential Therapeutic Target Involved in Immune Infiltration in Breast Cancer by Integrated Bioinformatical Analysis1
Ductal Carcinoma in situ: Underestimation of Percutaneous Biopsy and Positivity of Sentinel Lymph Node Biopsy in a Brazilian Public Hospital1
Effect of Heparinoid Moisturizer on Quality of Life in Patients with Acute Radiation Skin Damage Following Hypofractionated Radiation Therapy After Breast-Conserving Surgery: A Randomized Controlled S1
The Potent Novel CDK4/6 Inhibitor TQB3616 in Hormone Receptor Positive Breast Cancer: Preclinical Characterization with in vitro and Human Tumor Xenograft Models1
Pretreatment Circulating Albumin, Platelet, and RDW-SD Associated with Worse Disease-Free Survival in Patients with Breast Cancer1
Breast Cancer Awareness Among Medical Students, University of Bisha, Saudi Arabia1
A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Therapeutic Effect of Magnesium-L-Threonate Supplementation for Persistent Pain After Breast Cancer Surgery1
Critical Evaluation of Secondary Cancer Risk After Breast Radiation Therapy with Hybrid Radiotherapy Techniques1
Clinical Outcomes of Patients with HER2 Positive Metastatic Breast Cancer to the Brain, with First-Line Trastuzumab, Pertuzumab and Chemotherapy, in a Real-World Setting1
Anticarcinogenic Effects of Odorant Substances Citral, Citrathal R and Cyclovertal on Breast Cancer in vitro1
MCM-2 Levels as a Potential Biomarker for Predicting High-Risk Breast Cancer Patients According to TAILORx Classification1
Detecting the Frequency of c.5946delT Pathogenic Variant in the BRCA2 Gene and Associated Risk Factors Among Breast Cancer Patients Visiting Felege Hiwot Referral Hospital and University of Gondar Com1
Real-World Outcome and Prognostic Factors Among HER2-Positive Metastatic Breast Cancer Patients Receiving Pyrotinib-Based Therapy: A Multicenter Retrospective Analysis1
0.027297973632812